In the fiscal year 2020, the research and development (R&D) expenses of Taisho Pharmaceutical Holdings Co., Ltd. in Japan amounted to approximately billion Japanese yen, a decrease from around **** billion yen in the previous fiscal year.
The main products of the Japanese pharmaceutical company include over-the-counter medicines and prescription pharmaceuticals.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
Taisho. (December 21, 2021). Research and development (R&D) expenses of Taisho Pharmaceutical Holdings Co., Ltd. from fiscal year 2013 to 2020 (in billion Japanese yen) [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 29, 2026, from /statistics/1023312/taisho-pharmaceutical-research-development-expenses/
Taisho. "Research and development (R&D) expenses of Taisho Pharmaceutical Holdings Co., Ltd. from fiscal year 2013 to 2020 (in billion Japanese yen)." Chart. December 21, 2021. ÌÇÐÄÆÆ½â°æ. Accessed July 29, 2026. /statistics/1023312/taisho-pharmaceutical-research-development-expenses/
Taisho. (2021). Research and development (R&D) expenses of Taisho Pharmaceutical Holdings Co., Ltd. from fiscal year 2013 to 2020 (in billion Japanese yen). ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 29, 2026. /statistics/1023312/taisho-pharmaceutical-research-development-expenses/
Taisho. "Research and Development (R&d) Expenses of Taisho Pharmaceutical Holdings Co., Ltd. from Fiscal Year 2013 to 2020 (in Billion Japanese Yen)." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 21 Dec 2021, /statistics/1023312/taisho-pharmaceutical-research-development-expenses/
Taisho, Research and development (R&D) expenses of Taisho Pharmaceutical Holdings Co., Ltd. from fiscal year 2013 to 2020 (in billion Japanese yen) ÌÇÐÄÆÆ½â°æ, /statistics/1023312/taisho-pharmaceutical-research-development-expenses/ (last visited July 29, 2026)
Research and development (R&D) expenses of Taisho Pharmaceutical Holdings Co., Ltd. from fiscal year 2013 to 2020 (in billion Japanese yen) [Graph], Taisho, December 21, 2021. [Online]. Available: /statistics/1023312/taisho-pharmaceutical-research-development-expenses/